Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Submitted by
admin
on May 23, 2013 - 9:44am
Source:
The Fly on the Wall
News Tags:
Merrimack Pharmaceuticals
MM-121
breast cancer
Headline:
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Do Not Allow Advertisers to Use My Personal information
